Symphony Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.28M Buy
1,065
+20
+2% +$20.4K 0.57% 29
2026
Q1
$961K Sell
1,045
-79
-7% -$80.1K 0.49% 35
2025
Q4
$1.21M Buy
1,124
+53
+5% +$50.7K 0.62% 29
2025
Q3
$817K Buy
1,071
+488
+84% +$363K 0.44% 36
2025
Q2
$455K Sell
583
-45
-7% -$35K 0.27% 50
2025
Q1
$519K Sell
628
-147
-19% -$122K 0.34% 40
2024
Q4
$597K Sell
775
-293
-27% -$243K 0.48% 36
2024
Q3
$859K Buy
1,068
+176
+20% +$158K 0.73% 25
2024
Q2
$906K Buy
+892
New +$714K 0.78% 25

Other funds holding LLY

Symphony Financial Services's LLY Position: Q2 2026 in Review

Symphony Financial Services increased its Eli Lilly (LLY) stake by 1.9% in Q2 2026, buying an estimated $20.4K and bringing the position to 1,065 shares worth $1.28M. The position accounts for 0.57% of the portfolio, ranked #29.

Symphony Financial Services first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Symphony Financial Services held 1,065 shares of Eli Lilly worth $1.28M as of Q2 2026.
  • Symphony Financial Services bought 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.57% of Symphony Financial Services's portfolio in Q2 2026, its #29 holding.
  • Symphony Financial Services first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Symphony Financial Services's 13F filing for Q2 2026, filed 22 Jul 2026.